Literature DB >> 12670354

Reversible pulmonary hypertension and thalidomide therapy for multiple myeloma.

Tallal Hussein Younis1, Arif Alam, Pamela Paplham, Edward Spangenthal, Philip McCarthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12670354     DOI： 10.1046/j.1365-2141.2003.04245_2.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Pulmonary hypertension complicating multiple myeloma.

Authors:  Udhay Krishnan; Tomer M Mark; Ruben Niesvizky; Irina Sobol
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

2.  Pulmonary arterial hypertension in primary amyloidosis.

Authors:  Meghan M Cirulis; Lyska L Emerson; David A Bull; Nathan Hatton; Jose Nativi-Nicolai; Gerhard C Hildebrandt; John J Ryan
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

3.  Reversible pulmonary hypertension related to thalidomide treatment for multiple myeloma.

Authors:  Antonio Villa; Anna Alice Mazzola; Stefano Ghio; Elena Martinoli; Pietro Marino
Journal:  Case Rep Oncol       Date:  2011-09-28

Review 4.  Pulmonary hypertension and amyloidosis--an uncommon association: a case report and review of the literature.

Authors:  Lihi Eder; Devy Zisman; Raffael Wolf; Haim Bitterman
Journal:  J Gen Intern Med       Date:  2007-03       Impact factor: 5.128

5.  Thalidomide-Related Eosinophilic Pneumonia: A case report and brief literature review.

Authors:  Lisa Tilluckdharry; Robert Dean; Carol Farver; Muzaffar Ahmad
Journal:  Cases J       Date:  2008-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.